Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Treasury Shares (2016 - 2025)

Lipocine (LPCN) has disclosed Treasury Shares for 11 consecutive years, with $40712.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Treasury Shares changed 0.0% year-over-year to $40712.0, compared with a TTM value of $40712.0 through Sep 2025, changed 0.0%, and an annual FY2024 reading of $40712.0, changed 0.0% over the prior year.
  • Treasury Shares was $336.0 for Q3 2025 at Lipocine, roughly flat from $336.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $113795.0 in Q1 2024 and bottomed at $336.0 in Q4 2022.
  • Average Treasury Shares over 5 years is $13455.5, with a median of $5710.0 recorded in 2021.
  • Peak annual rise in Treasury Shares hit 0.0% in 2021, while the deepest fall reached 0.0% in 2021.
  • Year by year, Treasury Shares stood at $40712.0 in 2021, then changed by 0.0% to $40712.0 in 2022, then changed by 0.0% to $40712.0 in 2023, then changed by 0.0% to $40712.0 in 2024, then changed by 0.0% to $40712.0 in 2025.
  • Business Quant data shows Treasury Shares for LPCN at $40712.0 in Q3 2025, $40712.0 in Q2 2025, and $40712.0 in Q1 2025.